Equities

Charmacy Pharmaceutical Co Ltd

Charmacy Pharmaceutical Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)8.60
  • Today's Change0.00 / 0.00%
  • Shares traded1.50k
  • 1 Year change+5.01%
  • Beta0.0195
Data delayed at least 15 minutes, as of Jun 17 2024 06:25 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Charmacy Pharmaceutical Co., Ltd. is principally engaged in pharmaceutical products distribution in the People’s Republic of China (the PRC). The products also include healthcare medicine, traditional Chinese drinking tablets, traditional Chinese medicine and medical equipment. Through its subsidiaries, the Company is also engaged in the trading of pharmaceutical products and provision of related services.

  • Revenue in HKD (TTM)4.74bn
  • Net income in HKD55.29m
  • Incorporated1984
  • Employees831.00
  • Location
    Charmacy Pharmaceutical Co LtdNo. 235Song Shan North Road, Longhu DistrictSHANTOU 515041ChinaCHN
  • Phone+86 75 488206420
  • Fax+86 75 482752026
  • Websitehttps://www.chmyy.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Harima-Kyowa Co., LTD.3.06bn69.81m572.52m197.008.100.47217.910.1873261.75261.7511,459.404,490.241.9123.795.51--4.364.395.705.8711.5711.732.282.232.22--0.013117.152.375.011.103.2534.303.44
Natural Health Trends Corp.335.97m3.90m619.79m138.00158.652.02121.701.840.04340.04343.753.420.5822.24--311,695.700.6751-0.53980.9333-0.709974.3074.061.16-0.95712.77--0.00---10.60-25.5481.47-54.86-26.476.64
Balaxi Pharmaceuticals Ltd225.57m-2.23m624.17m51.00--3.27--2.77-0.566-0.56646.7536.960.9691.374.47---0.958619.81-1.2227.3046.6735.46-0.989311.952.3626.610.0879---28.2877.76-105.19--5.11--
111 Inc - ADR15.91bn-403.34m722.28m1.52k------0.0454-0.6094-0.609424.02-1.044.809.6232.621,340,126.00-10.93-17.09---178.255.565.36-2.28-4.370.5234-19.990.4256--10.5952.955.80---7.89--
Sopharma Trading AD7.40bn134.79m864.30m2.73k6.411.483.160.11680.92010.920150.503.982.660.15867.16661,702.604.852.3914.877.8897.9898.091.821.010.6231185.950.6107--13.0213.26221.6727.863.70--
Pharmaniaga Berhad5.77bn-94.60m882.53m3.48k----57.000.1528-0.042-0.0422.52-0.18881.674.916.101,003,736.00-2.64-7.15-246.02-43.709.666.48-1.59-3.810.33221.571.25---2.207.3887.27--28.98--
Charmacy Pharmaceutical Co Ltd4.74bn55.29m928.80m831.0016.801.4411.080.19590.5120.51243.915.961.446.054.885,706,857.001.681.798.287.996.346.081.171.240.77752.790.511137.095.472.27-43.252.48-16.010.0027
Profarma Distribuidora de Produts Frm SA12.91bn112.02m962.36m7.08k8.510.52292.780.07450.62890.628972.5010.231.774.677.67--1.701.644.063.4014.9714.610.96180.95190.76961.850.4552--10.8215.19-12.95--41.08--
CM Hospitalar SA16.33bn473.73m1.00bn7.00k2.070.20741.150.06151.041.0436.9310.321.125.564.671,606,019.003.254.004.516.1515.1315.892.903.501.681.560.576--26.7233.2238.5760.22-2.72--
EQL Pharma AB196.30m16.87m1.11bn21.0067.268.41--5.660.76420.76428.886.120.80121.744.8012,579,430.006.899.0211.9015.2743.5537.958.598.290.56948.880.4032--1.6439.64-26.57--32.73--
Data as of Jun 17 2024. Currency figures normalised to Charmacy Pharmaceutical Co Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.